Assessment of extracranial metastatic disease in patients with brain metastases: How much effort is needed in the context of evolving survival prediction models?
Brain metastases
Extracranial metastases
Prognostic score
Radiotherapy
Survival prediction
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
18
12
2020
revised:
20
02
2021
accepted:
23
02
2021
pubmed:
7
3
2021
medline:
29
6
2021
entrez:
6
3
2021
Statut:
ppublish
Résumé
Survival prediction models may serve as decision-support tools for clinicians who have to assign the right treatment to each patient, in a manner whereby harmful over- or undertreatment is avoided as much as possible. Current models differ regarding their components, the overall number of components and the weighting of individual components. Some of the components are easy to assess, such as age or primary tumor type. Others carry the risk of inter-assessor inconsistency and time-dependent variation. The present publication focuses on issues related to assessment of extracranial metastases and potential surrogates, e.g. blood biomarkers. It identifies areas of controversy and provides recommendations for future research projects, which may contribute to prognostic models with improved accuracy.
Identifiants
pubmed: 33675870
pii: S0167-8140(21)06112-0
doi: 10.1016/j.radonc.2021.02.038
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
17-20Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.